After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years, in an ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...

Vaccine manufacturer GSK announced Thursday it will invest $800 million to expand its Marietta location, creating 200 jobs ...

GSK (GSK) plc announced what it calls its “largest U.S. manufacturing investment to date.” The up to $800M investment will bring ...

Global biopharma company GSK is investing up to $800 million in Pennsylvania and expanding its facility in Lancaster County.

READ: East Donegal Twp. supervisors approve GSK Marietta expansion that would add 150 jobs Supervisors approved GSK Marietta’s land development plan that provided for the demolition of a ...

FDA accepted GSK's gepotidacin application for uUTI treatment with a PDUFA date set for March 26, 2025. Gepotidacin showed superior efficacy over nitrofurantoin in EAGLE-3 trial with a 58.5% ...

Recommended Reading Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

On Wednesday, the FDA accepted GSK plc’s (NYSE:GSK) marketing application seeking approval for gepotidacin, an investigational, oral antibiotic for adult and adolescent females with ...